These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 14248536)
1. ANTICOAGULANT ACTIVITY OF ACENOCOUMARIN IN EXPERIMENTAL ANIMALS. JINDAL MN; SHAH DS Indian J Physiol Pharmacol; 1964 Jan; 8():72-9. PubMed ID: 14248536 [No Abstract] [Full Text] [Related]
2. ADMINISTRATION AND CONTROL OF ANTICOAGULANT TREATMENT. POLLER L Manch Med Gaz; 1964; 43():8-11. PubMed ID: 14125255 [No Abstract] [Full Text] [Related]
3. TURNOVER OF PROTHROMBIN AND FACTORS VII, IX AND X IN STATES OF HYPOCOAGULABILITY. HELLEMANS J; DEVREKER R; VORLAT M; VERSTRAETE M Acta Haematol; 1963 Jul; 30():35-41. PubMed ID: 14045902 [No Abstract] [Full Text] [Related]
4. Some aspects of the pharmacology of oral anticoagulants. Coon WW; Willis PW Clin Pharmacol Ther; 1970; 11(3):312-36. PubMed ID: 4192279 [No Abstract] [Full Text] [Related]
5. [REPORT ON EXPERIENCES WITH A 6-YEAR CONTINUOUS ANTICOAGULANT TREATMENT]. TVERDY E Wien Z Inn Med; 1964 Feb; 45():55-7. PubMed ID: 14155961 [No Abstract] [Full Text] [Related]
6. DRUG-INDUCED INCREASE OF PROTHROMBIN COMPLEX ACTIVITY IN VIVO. WEINER M; DAYTON PG Am J Med Sci; 1964 Jan; 247():75-83. PubMed ID: 14106883 [No Abstract] [Full Text] [Related]
7. THE EFFECT OF ANTICOAGULANTS ON THE HIGH-ENERGY PHOSPHATE CONTENT OF RAT AURICLES. WOSILAIT WD Biochem Pharmacol; 1963 Aug; 12():803-8. PubMed ID: 14071537 [No Abstract] [Full Text] [Related]
10. DO BARBITURATES INFLUENCE THE PROTHROMBIN-PROCONVERTIN LEVEL DURING ANTICOAGULANT THERAPY? SAMUELSSON SM; LILIENBERG G Scand J Clin Lab Invest; 1965; 17():73-9. PubMed ID: 14260757 [No Abstract] [Full Text] [Related]
11. [Tromexan and marcoumar in anticoagulant therapy; micromethod for determination of prothrombin-proconvertin activity]. IVERSEN T Ugeskr Laeger; 1955 Jul; 117(27):873-8. PubMed ID: 13256759 [No Abstract] [Full Text] [Related]
12. [ON BLOOD COAGULATION CHANGES AND THE ANTICOAGULANT EFFECT OF MONOAMINE OXIDASE INHIBITORS]. HRDINA P; KOVALCIK V Cas Lek Cesk; 1963 May; 102():574-9. PubMed ID: 14051515 [No Abstract] [Full Text] [Related]
13. Anticoagulant therapy with tromexan and marcoumar and determination of the prothrombin-proconvertin activity by a micro-method. IVERSEN T Acta Med Scand; 1956 Sep; 155(3):161-70. PubMed ID: 13361829 [No Abstract] [Full Text] [Related]
14. [THE COURSE OF CORONARY HEART DISEASE UNDER ANTICOAGULANT TREATMENT]. GIBERT QUERALTO J; LOZANO PEREZ J; VILALTA BERNET C; TORNER SOLER M; CASELLAS BERNAT A; TRILLA SANCHEZ E; BALAGUER VINTRO I Actual Cardiol Angeiol Int (Paris); 1964; 13():23-9. PubMed ID: 14185513 [No Abstract] [Full Text] [Related]
15. [MODIFICATION OF ANTICOAGULANT THERAPY BY A DIURETIC]. VINAZZER H Wien Z Inn Med; 1963 Jul; 44():323-7. PubMed ID: 14048088 [No Abstract] [Full Text] [Related]
16. [PRIMARY IDIOPATHIC HYPERACTIVITY OF PROTHROMBIN AND FACTOR VII]. GAY A; ALZETTA A; MONTALE P Arch Maragliano Patol Clin; 1963 Dec; 19():785-91. PubMed ID: 14120627 [No Abstract] [Full Text] [Related]
17. [Metabolism of a derivative of 4-hydroxy-coumarin: 3(alfa-acetonyl-p-nitrobenzyl)4-hydroxy-coumarin (Sintrom) in man]. Blatrix C; Charonnat S; Tillement JP; Israel J; Brevet JP; Debraux J; Merlin M Rev Fr Etud Clin Biol; 1968 Dec; 13(10):984-95. PubMed ID: 4185223 [No Abstract] [Full Text] [Related]
18. [SKIN NECROSES IN ANTICOAGULANT THERAPY]. STACHER A Wien Z Inn Med; 1964 Feb; 45():47-9. PubMed ID: 14155957 [No Abstract] [Full Text] [Related]